Finerenone and Estimated GFR Slope in Type 2 Diabetes and CKD

Saved in:
Bibliographic Details
Main Authors: Masayuki Yamanouchi, Yuki Oba, Hisashi Kamido, Masatoshi Yoshimoto, Yusuke Yoshimura, Hisashi Sugimoto, Shigekazu Kurihara, Akinari Sekine, Tatsuya Suwabe, Naoki Sawa, Takehiko Wada, Kengo Furuichi, Takashi Wada, Yoshifumi Ubara
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Kidney International Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024925002256
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849419460319903744
author Masayuki Yamanouchi
Yuki Oba
Hisashi Kamido
Masatoshi Yoshimoto
Yusuke Yoshimura
Hisashi Sugimoto
Shigekazu Kurihara
Akinari Sekine
Tatsuya Suwabe
Naoki Sawa
Takehiko Wada
Kengo Furuichi
Takashi Wada
Yoshifumi Ubara
author_facet Masayuki Yamanouchi
Yuki Oba
Hisashi Kamido
Masatoshi Yoshimoto
Yusuke Yoshimura
Hisashi Sugimoto
Shigekazu Kurihara
Akinari Sekine
Tatsuya Suwabe
Naoki Sawa
Takehiko Wada
Kengo Furuichi
Takashi Wada
Yoshifumi Ubara
author_sort Masayuki Yamanouchi
collection DOAJ
format Article
id doaj-art-892c48a796de4e6c8f87914a9886cae2
institution Kabale University
issn 2468-0249
language English
publishDate 2025-07-01
publisher Elsevier
record_format Article
series Kidney International Reports
spelling doaj-art-892c48a796de4e6c8f87914a9886cae22025-08-20T03:32:04ZengElsevierKidney International Reports2468-02492025-07-011072461246510.1016/j.ekir.2025.04.012Finerenone and Estimated GFR Slope in Type 2 Diabetes and CKDMasayuki Yamanouchi0Yuki Oba1Hisashi Kamido2Masatoshi Yoshimoto3Yusuke Yoshimura4Hisashi Sugimoto5Shigekazu Kurihara6Akinari Sekine7Tatsuya Suwabe8Naoki Sawa9Takehiko Wada10Kengo Furuichi11Takashi Wada12Yoshifumi Ubara13Nephrology Center, Toranomon Hospital, Tokyo, Japan; Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan; Okinaka Memorial Institute for Medical Research, Tokyo, Japan; Department of Nephrology and Rheumatology, Kanazawa University, Ishikawa, Japan; Department of Nephrology, Kanazawa Medical University School of Medicine, Ishikawa, Japan; Correspondence: Masayuki Yamanouchi, Nephrology Center, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan.Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital, Tokyo, JapanNephrology Center, Toranomon Hospital, Tokyo, Japan; Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital, Tokyo, Japan; Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital, Tokyo, JapanDepartment of Nephrology, Kanazawa Medical University School of Medicine, Ishikawa, JapanDepartment of Nephrology and Rheumatology, Kanazawa University, Ishikawa, JapanNephrology Center, Toranomon Hospital, Tokyo, Japan; Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japanhttp://www.sciencedirect.com/science/article/pii/S2468024925002256chronic kidney diseaseeGFR slopefinerenonenonsteroidal mineralocorticoid receptor (MR) antagonistreal-world studytype 2 diabetes mellitus
spellingShingle Masayuki Yamanouchi
Yuki Oba
Hisashi Kamido
Masatoshi Yoshimoto
Yusuke Yoshimura
Hisashi Sugimoto
Shigekazu Kurihara
Akinari Sekine
Tatsuya Suwabe
Naoki Sawa
Takehiko Wada
Kengo Furuichi
Takashi Wada
Yoshifumi Ubara
Finerenone and Estimated GFR Slope in Type 2 Diabetes and CKD
Kidney International Reports
chronic kidney disease
eGFR slope
finerenone
nonsteroidal mineralocorticoid receptor (MR) antagonist
real-world study
type 2 diabetes mellitus
title Finerenone and Estimated GFR Slope in Type 2 Diabetes and CKD
title_full Finerenone and Estimated GFR Slope in Type 2 Diabetes and CKD
title_fullStr Finerenone and Estimated GFR Slope in Type 2 Diabetes and CKD
title_full_unstemmed Finerenone and Estimated GFR Slope in Type 2 Diabetes and CKD
title_short Finerenone and Estimated GFR Slope in Type 2 Diabetes and CKD
title_sort finerenone and estimated gfr slope in type 2 diabetes and ckd
topic chronic kidney disease
eGFR slope
finerenone
nonsteroidal mineralocorticoid receptor (MR) antagonist
real-world study
type 2 diabetes mellitus
url http://www.sciencedirect.com/science/article/pii/S2468024925002256
work_keys_str_mv AT masayukiyamanouchi finerenoneandestimatedgfrslopeintype2diabetesandckd
AT yukioba finerenoneandestimatedgfrslopeintype2diabetesandckd
AT hisashikamido finerenoneandestimatedgfrslopeintype2diabetesandckd
AT masatoshiyoshimoto finerenoneandestimatedgfrslopeintype2diabetesandckd
AT yusukeyoshimura finerenoneandestimatedgfrslopeintype2diabetesandckd
AT hisashisugimoto finerenoneandestimatedgfrslopeintype2diabetesandckd
AT shigekazukurihara finerenoneandestimatedgfrslopeintype2diabetesandckd
AT akinarisekine finerenoneandestimatedgfrslopeintype2diabetesandckd
AT tatsuyasuwabe finerenoneandestimatedgfrslopeintype2diabetesandckd
AT naokisawa finerenoneandestimatedgfrslopeintype2diabetesandckd
AT takehikowada finerenoneandestimatedgfrslopeintype2diabetesandckd
AT kengofuruichi finerenoneandestimatedgfrslopeintype2diabetesandckd
AT takashiwada finerenoneandestimatedgfrslopeintype2diabetesandckd
AT yoshifumiubara finerenoneandestimatedgfrslopeintype2diabetesandckd